Vol 14, No 1 (February 28, 2025): Chinese Clinical Oncology

Original Article

A sub-cluster of cancer cells indicates poor prognosis in advanced hepatocellular carcinoma
Hai-Feng Zhou, Wei Yang, Fei-Da Wu, Di Zhu, Yu-Guan Xie, Bi-Fei Wu, Zhi-Hui Hong, Hai-Bin Shi, Sheng Liu, Wei-Zhong Zhou
Chinese Clinical Oncology  
2025;
14
(1)
:1
.
Associations between dietary intake of zinc and selenium and breast cancer: findings from a NHANES cross-sectional study
Yanbo Wang, Zhen Du, Haowei Du, Jianchun Zhao, Yuting Duan, Aimin Wang
Chinese Clinical Oncology  
2025;
14
(1)
:2
.
Comparative prognosis of liver transplantation versus liver resection in intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
Ying Chen, Hongyu Shen, Ruiqin Xu, Jiahai Zhu, Ya Zhu, Hao Zou
Chinese Clinical Oncology  
2025;
14
(1)
:3
.
Novel treatment vs. standard of care in melanoma-associated leptomeningeal metastases: a systematic review and network meta-analysis
Jia Jia Teo, Angad Chauhan, Razan Nossier, Tuan Zea Tan, Vincent Diong Weng Nga
Chinese Clinical Oncology  
2025;
14
(1)
:4
.

Surgical Technique

Robotic-assisted trans-mesocolic side-to-side duodenojejunostomy for palliative management of malignant distal duodenal obstruction
Han Yin, Devesh Sharma, Jaeyun Jane Wang, Amir Ashraf Ganjouei, Abdul Kouanda, Kenzo Hirose, Eric Nakakura, Kimberly Kirkwood, Carlos Corvera, Adnan Alseidi, Mohamed Abdelgadir Adam
Chinese Clinical Oncology  
2025;
14
(1)
:5
.

Review Article

Bibliometrics of gastric cancer prediction models
Fei Gao, Xiaohan Wang, Xifeng Fu, Jingchao Sun
Chinese Clinical Oncology  
2025;
14
(1)
:6
.
Immunotherapy resistance in colorectal cancer with liver metastases: challenges & therapeutic advances
Nosakhare Paul Ilerhunmwuwa, Ibrahim Halil Sahin, Anwaar Saeed
Chinese Clinical Oncology  
2025;
14
(1)
:7
.
Challenges and considerations in non-inferiority trials: a narrative review from statisticians’ perspectives
Ruizhe Chen, Qian Shi
Chinese Clinical Oncology  
2025;
14
(1)
:8
.
Intriguing future: single-site robotic-assisted radical prostatectomy
Di Gu, Yubo Wang, Yifan Chang, Yongda Liu, Mingzhao Li, Chao Cai, Shancheng Ren, Guohua Zeng
Chinese Clinical Oncology  
2025;
14
(1)
:9
.
Pediatric radiotherapy preparation: a scoping review
Sam Y. C. Chan, Kelvin C. K. Liu, Jerry C. F. Ching, Anthony P. Y. Liu, Shara W. Y. Lee
Chinese Clinical Oncology  
2025;
14
(1)
:10
.

Case Report

A periungual eccrine poroma masquerading as amelanotic melanoma: a case report
Sha Yi, Shang-Shang Wang
Chinese Clinical Oncology  
2025;
14
(1)
:11
.

Editorial Commentary

Befotertinib: one more drug targeting EGFR—the more may be the merrier
Guilherme Sacchi de Camargo Correia, Yanyan Lou, Rami Manochakian
Chinese Clinical Oncology  
2025;
14
(1)
:12
.
Is metastasis-directed local therapy the new standard of care for patients with oligometastasic esophageal squamous cell carcinoma?—a perspective on the ESO-Shanghai 13 Trial
Neil B. Newman, Krishan R. Jethwa
Chinese Clinical Oncology  
2025;
14
(1)
:13
.
A new era for EGFR exon20 targeting in non-small cell lung cancer
Petros Christopoulos
Chinese Clinical Oncology  
2025;
14
(1)
:14
.
Papillon trial, a major advance in the management of patients with metastatic, mutated-EGFR exon 20 insertion non-small-cell lung cancer
Christos Chouaïd, Jean-Baptiste Assié, Jean-Bernard Auliac
Chinese Clinical Oncology  
2025;
14
(1)
:15
.